The future of medicine

Digital clinic with proteome analysis

The global challenge we face is the rising prevalence of chronic diseases. The most crucial step in preventing pandemics like COVID-19 is to minimize the prevalence of chronic diseases in the population. At present, these conditions are often detected only after significant organ damage has occurred, making them difficult or impossible to halt.

Early detection and treatment of conditions, such as cardiovascular and kidney diseases, could help mitigate this issue. A key problem in the current healthcare system is that physicians are overwhelmed by their daily workload, leaving them unable to stay current with the latest medical advancements. Digital knowledge resources and molecular analyses are essential for doctors to remain up-to-date.

This can be achieved through the use of artificial intelligence to manage proteomic data, combined with published clinical literature and patient data. This approach would enable the identification of disease origins, progression, and appropriate treatments. Such insights will be crucial for guiding interventions and making necessary adjustments to lifestyle and nutrition.

Through the implementation of a digital clinic, mosaiques will also bypass regulations like the "cost-effectiveness bonus" in Germany.

This bonus incentivizes general practitioners to avoid conducting diagnostic laboratory tests, rather than ensuring that patients with statutory health insurance receive their right to diagnostics. The law, based on Section 87 Paragraph 1 Clause 1 of the Social Code Book V – Resolution 412 – took effect on January 1, 2018, and was established by the National Association of Statutory Health Insurance Physicians and the Association of Statutory Health Insurance Funds, as members of the Federal Joint Committee.